Functionalized polymer microbubbles as new molecular ultrasound contrast agent to target P-selectin in thrombus.


Journal

Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316

Informations de publication

Date de publication:
02 2019
Historique:
received: 03 09 2018
revised: 28 11 2018
accepted: 20 12 2018
pubmed: 30 12 2018
medline: 19 5 2020
entrez: 30 12 2018
Statut: ppublish

Résumé

Thrombotic diseases rarely cause symptoms until advanced stage and sudden death. Thus, early detection of thrombus by a widely spread imaging modality can improve the prognosis and reduce mortality. Here, polymer microbubbles (MBs) made of degradable poly(IsoButylCyanoAcrylate) and functionalized with fucoidan (Fucoidan-MBs) were designed as a new targeted ultrasound contrast agent to image venous thrombus. The physicochemical characterizations demonstrate that the MBs with fucoidan surface exhibit a size of 2-6 μm and stability in suspension at 4 °C up to 2 months. MBs exhibit high echogenicity and could be completely burst under high destructive pulse. Flow chamber experiments on activated human platelets show a higher affinity of Fucoidan-MBs than control anionic MBs (CM-Dextran-MBs) under shear stress conditions. In vivo analysis by ultrasound and histological results demonstrate that Fucoidan-MBs are localized in rat venous thrombotic wall, whereas few CM-Dextran-MBs are present. In addition, the binding of Fucoidan-MBs in healthy vein is not observed. Collectively, Fucoidan-MBs appear as a promising functionalized carrier for ultrasound molecular imaging in thrombotic diseases.

Identifiants

pubmed: 30593939
pii: S0142-9612(18)30858-5
doi: 10.1016/j.biomaterials.2018.12.023
pii:
doi:

Substances chimiques

Contrast Media 0
P-Selectin 0
Polysaccharides 0
Bucrylate 2HJV1F859Z
fucoidan 9072-19-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

139-150

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Auteurs

Bo Li (B)

INSERM, U1148, Laboratory for Vascular Translational Science, CHU X. Bichat, Paris Diderot University, 46 Rue H. Huchard, 75018 Paris, France; Institut Galilée, Paris 13 University, 99 Avenue JB Clément, 93430 Villetaneuse, France; Key Laboratory of Biomaterials of Guangdong Higher Education Institute, Department of Biomedical Engineering, Jinan University, Guangzhou 510632, China.

Rachida Aid-Launais (R)

INSERM, U1148, Laboratory for Vascular Translational Science, CHU X. Bichat, Paris Diderot University, 46 Rue H. Huchard, 75018 Paris, France; Institut Galilée, Paris 13 University, 99 Avenue JB Clément, 93430 Villetaneuse, France.

Marie-Noëlle Labour (MN)

INSERM, U1148, Laboratory for Vascular Translational Science, CHU X. Bichat, Paris Diderot University, 46 Rue H. Huchard, 75018 Paris, France; Institut Galilée, Paris 13 University, 99 Avenue JB Clément, 93430 Villetaneuse, France.

Alina Zenych (A)

INSERM, U1148, Laboratory for Vascular Translational Science, CHU X. Bichat, Paris Diderot University, 46 Rue H. Huchard, 75018 Paris, France; Institut Galilée, Paris 13 University, 99 Avenue JB Clément, 93430 Villetaneuse, France.

Maya Juenet (M)

INSERM, U1148, Laboratory for Vascular Translational Science, CHU X. Bichat, Paris Diderot University, 46 Rue H. Huchard, 75018 Paris, France; Institut Galilée, Paris 13 University, 99 Avenue JB Clément, 93430 Villetaneuse, France.

Christine Choqueux (C)

INSERM, U1148, Laboratory for Vascular Translational Science, CHU X. Bichat, Paris Diderot University, 46 Rue H. Huchard, 75018 Paris, France; Institut Galilée, Paris 13 University, 99 Avenue JB Clément, 93430 Villetaneuse, France.

Véronique Ollivier (V)

INSERM, U1148, Laboratory for Vascular Translational Science, CHU X. Bichat, Paris Diderot University, 46 Rue H. Huchard, 75018 Paris, France; Institut Galilée, Paris 13 University, 99 Avenue JB Clément, 93430 Villetaneuse, France.

Olivier Couture (O)

Institut Langevin - Ondes et Images, ESPCI ParisTech, PSL Research University, CNRS UMR7587, INSERM U979, 1, Rue Jussieu, 75238 Paris, Cedex 05, France.

Didier Letourneur (D)

INSERM, U1148, Laboratory for Vascular Translational Science, CHU X. Bichat, Paris Diderot University, 46 Rue H. Huchard, 75018 Paris, France; Institut Galilée, Paris 13 University, 99 Avenue JB Clément, 93430 Villetaneuse, France.

Cédric Chauvierre (C)

INSERM, U1148, Laboratory for Vascular Translational Science, CHU X. Bichat, Paris Diderot University, 46 Rue H. Huchard, 75018 Paris, France; Institut Galilée, Paris 13 University, 99 Avenue JB Clément, 93430 Villetaneuse, France. Electronic address: cedric.chauvierre@inserm.fr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH